Seferovic, J. P., Claggett, B., Seidelmann, S. B., Seely, E. W., Packer, M., Zile, M. R., … Solomon, S. D. (2017). Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. The Lancet Diabetes & Endocrinology, 5(5), 333–340. https://doi.org/10.1016/s2213-8587(17)30087-6

Seferovic, Jelena P., Brian Claggett, Sara B. Seidelmann, Ellen W. Seely, Milton Packer, Michael R. Zile, Jean L. Rouleau, et al. “Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.” The Lancet Diabetes & Endocrinology 5, no. 5 (May 2017): 333–40. https://doi.org/10.1016/s2213-8587(17)30087-6.

Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, et al. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. The Lancet Diabetes & Endocrinology. 2017 May;5(5):333–40.

Seferovic, Jelena P., et al. “Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.” The Lancet Diabetes & Endocrinology, vol. 5, no. 5, Elsevier BV, May 2017, pp. 333–40. Crossref, doi:10.1016/s2213-8587(17)30087-6.

Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJV, Solomon SD. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. The Lancet Diabetes & Endocrinology. Elsevier BV; 2017 May;5(5):333–340.